TTRX
Turn Therapeutics Inc.
Company overview
- Market capitalization
- $388.44M
- Employees
- 2
- Latest publication
- 2026-09-29
About Turn Therapeutics Inc.
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|
| Cost Of Revenue | 14,451USD | 14,155USD | 13,679USD | — | — |
| Gross Profit | -14,451USD | -14,155USD | -13,679USD | — | — |
| Research Development | 109,434USD | 34,934USD | 158,699USD | 62,678USD | 73,982USD |
| Unclassified Operating Expenses | 1,122,258USD | 2,144,481USD | 1,741,177USD | — | — |
| Total Operating Expenses | 1,231,692USD | 2,179,415USD | 1,899,876USD | 1,366,524USD | 360,180USD |
| Operating Income | -1,246,143USD | -2,193,570USD | -1,913,555USD | -1,366,524USD | -360,180USD |
| Income Before Tax | -970,972USD | 279,070USD | -1,904,184USD | -1,240,415USD | -351,936USD |
| Net Income | -970,972USD | 279,070USD | -1,904,184USD | -1,240,415USD | -351,936USD |
| Ebit | -1,246,143USD | -2,193,570USD | -1,913,555USD | — | — |
| Ebitda | -1,231,692USD | -2,179,415USD | -1,899,876USD | -1,366,524USD | -360,180USD |
| Depreciation And Amortization | 14,451USD | 14,155USD | 13,679USD | — | — |
| Total Other Income Expense Net | 275,171USD | 2,472,640USD | 9,371USD | 126,109USD | 8,244USD |
| Total Revenue | — | — | — | 0USD | 0USD |
| Selling General Administrative | — | — | — | 1,303,846USD | 286,198USD |
| Interest Income | — | — | — | 5,134USD | 8,244USD |
| Net Interest Income | — | — | — | 5,134USD | 8,244USD |
| Net Income From Continuing Ops | — | — | — | -1,240,415USD | -351,936USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Research Development | 265,570USD | 245,956USD | 7,500USD |
| Selling General Administrative | 5,593,078USD | 1,551,168USD | 2,300,649USD |
| Total Operating Expenses | 5,858,648USD | 1,797,124USD | 2,308,149USD |
| Operating Income | -5,858,648USD | -1,797,124USD | -2,308,149USD |
| Income Before Tax | -3,194,080USD | -1,768,415USD | -2,292,267USD |
| Net Income | -3,194,080USD | -1,768,415USD | -2,292,267USD |
| Ebit | -5,858,648USD | -1,797,124USD | -2,308,149USD |
| Ebitda | -5,805,902USD | -1,749,641USD | -2,264,229USD |
| Depreciation And Amortization | 52,746USD | 47,483USD | 43,920USD |
| Total Other Income Expense Net | 2,664,568USD | 28,709USD | 15,882USD |
| Total Revenue | — | 0USD | 0USD |
| Interest Income | — | 28,709USD | 15,882USD |
| Net Interest Income | — | 28,709USD | 15,882USD |
| Net Income From Continuing Ops | — | -1,768,415USD | -2,292,267USD |
| Reconciled Depreciation | — | 47,483USD | 43,920USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 16,960,719USD | 18,644,136USD | 12,162,241USD | 4,350,329USD | 4,331,302USD | — |
| Cash And Equivalents | 9,948,952USD | — | — | — | — | — |
| Total Current Assets | 10,428,198USD | 11,452,842USD | 5,196,444USD | 3,294,740USD | 3,393,961USD | — |
| Other Current Assets | 139,688USD | 235,171USD | 120,300USD | 188,583USD | 204,018USD | — |
| Total Liabilities | 16,273,831USD | — | — | — | — | — |
| Total Current Liabilities | 8,764,111USD | 5,130,522USD | 6,003,424USD | 2,309,254USD | 1,060,752USD | — |
| Total Stockholder Equity | 686,888USD | 6,117,548USD | 4,686,723USD | 556,718USD | 1,774,496USD | — |
| Total Equity Including Noncontrolling Interest | 686,888USD | — | — | — | — | — |
| Long Term Debt | 6,062,994USD | — | — | — | — | — |
| Deferred Revenue Non Current | 1,438,013USD | — | — | — | — | — |
| Property Plant Equipment Net | 56,275USD | 67,573USD | — | 89,423USD | 99,989USD | — |
| Intangible Assets | 911,219USD | 919,947USD | 922,171USD | 904,885USD | 828,770USD | — |
| Short Term Debt | 49,329USD | 47,795USD | 46,295USD | 44,829USD | 43,405USD | — |
| Common Stock | 2,977USD | 2,977USD | 2,943USD | 2,802USD | 1,401USD | — |
| Retained Earnings | -29,210,958USD | -23,361,065USD | -22,390,093USD | -22,669,163USD | -20,764,985USD | — |
| Total Liab | — | 12,526,588USD | 7,475,518USD | 3,793,611USD | 2,556,806USD | — |
| Other Current Liab | — | 2,767,462USD | 3,028,401USD | — | 1,017,347USD | — |
| Cash | — | 11,217,671USD | 5,076,144USD | 3,106,157USD | 3,189,943USD | — |
| Cash And Short Term Investments | — | 11,217,671USD | 5,076,144USD | 3,106,157USD | 3,189,943USD | — |
| Net Debt | — | -5,211,823USD | -4,995,768USD | -3,014,984USD | -3,088,497USD | — |
| Short Long Term Debt Total | — | 6,005,848USD | 80,376USD | 91,173USD | 101,446USD | — |
| Accounts Payable | — | 2,315,265USD | 2,928,728USD | 2,264,425USD | — | — |
| Common Stock Shares Outstanding | — | 29,476,000shares | 29,445,183shares | 28,022,826shares | 13,743,900shares | 13,335,043shares |
| Non Current Assets Total | — | 7,191,293USD | 6,965,797USD | 1,055,589USD | 937,341USD | — |
| Non Current Liabilities Total | — | 7,396,066USD | 1,472,094USD | 1,484,356USD | 1,496,054USD | — |
| Non Currrent Assets Other | — | 6,203,773USD | 6,043,626USD | 8,582USD | 8,582USD | — |
| Unclassified Non Current Liabilities | — | 7,396,066USD | 1,472,094USD | 1,484,356USD | 1,496,054USD | — |
| Unclassified Equity | — | 29,475,636USD | 27,073,873USD | 23,223,079USD | 22,536,679USD | — |
| Capital Stock | — | — | — | — | 1,401USD | — |
| Property Plant Equipment Gross | — | — | — | — | 99,989USD | — |
| Net Working Capital | — | — | — | — | 2,333,209USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Total Assets | 12,162,241USD | 2,048,889USD | 2,013,560USD |
| Intangible Assets | 922,171USD | 821,931USD | 769,939USD |
| Other Current Assets | 120,300USD | 225,325USD | 20,820USD |
| Total Liab | 7,475,518USD | 2,226,321USD | 1,927,792USD |
| Total Stockholder Equity | 4,686,723USD | -177,432USD | 85,768USD |
| Other Current Liab | 3,028,401USD | 667,272USD | 464,623USD |
| Common Stock | 2,943USD | 1,342USD | 1,324USD |
| Retained Earnings | -22,390,093USD | -19,196,013USD | -17,427,598USD |
| Cash | 5,076,144USD | 872,599USD | 1,180,997USD |
| Cash And Short Term Investments | 5,076,144USD | 872,599USD | 1,180,997USD |
| Total Current Assets | 5,196,444USD | 1,097,924USD | 1,201,817USD |
| Total Current Liabilities | 6,003,424USD | 707,932USD | 489,779USD |
| Net Debt | -4,995,768USD | -751,563USD | -1,155,841USD |
| Short Term Debt | 46,295USD | 40,660USD | 25,156USD |
| Short Long Term Debt Total | 80,376USD | 121,036USD | 25,156USD |
| Accounts Payable | 2,928,728USD | — | — |
| Common Stock Shares Outstanding | 13,743,900shares | 13,422,845shares | 13,247,241shares |
| Non Current Assets Total | 6,965,797USD | 950,965USD | 811,743USD |
| Non Current Liabilities Total | 1,472,094USD | 1,518,389USD | 1,438,013USD |
| Non Currrent Assets Other | 6,043,626USD | 8,582USD | 8,582USD |
| Unclassified Non Current Liabilities | 1,472,094USD | 1,518,389USD | 1,438,013USD |
| Unclassified Equity | 27,073,873USD | 19,015,897USD | 17,510,718USD |
| Capital Stock | — | 1,342USD | 1,324USD |
| Property Plant Equipment Net | — | 120,452USD | 33,222USD |
| Property Plant Equipment Gross | — | 120,452USD | 33,222USD |
| Net Working Capital | — | 389,992USD | 712,038USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|
| Net Income | -970,972USD | 279,070USD | -1,904,184USD | -1,240,415USD | -351,936USD |
| Depreciation | 14,451USD | 14,155USD | 13,679USD | — | — |
| Other Non Cash Items | 60,916USD | -2,202,078USD | 39,382USD | 61,157USD | — |
| Change In Working Capital | -737,202USD | 732,586USD | 1,262,513USD | 679,292USD | — |
| Total Cash From Operating Activities | -1,632,807USD | -1,176,267USD | -588,610USD | -499,966USD | — |
| Capital Expenditures | -3USD | -3USD | 0USD | -4USD | 0USD |
| Free Cash Flow | -1,632,810USD | -1,176,270USD | -588,610USD | -499,970USD | — |
| Total Cashflows From Investing Activities | -12,227USD | -31,440USD | -89,794USD | -31,751USD | — |
| Total Cash From Financing Activities | 7,786,561USD | 3,177,696USD | 594,617USD | 2,149,027USD | — |
| Change In Cash | 6,141,527USD | 1,969,987USD | -83,786USD | 3,189,943USD | — |
| Begin Period Cash Flow | 5,076,144USD | 3,106,157USD | 3,189,943USD | — | — |
| End Period Cash Flow | 11,217,671USD | 5,076,144USD | 3,106,157USD | 3,189,943USD | — |
| Other Cashflows From Financing Activities | 1,070,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | 6,716,561USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Net Income | -3,194,080USD | -1,768,415USD | -2,292,267USD |
| Depreciation | 52,746USD | 47,483USD | 43,920USD |
| Stock Based Compensation | 419,245USD | 352,833USD | 640,264USD |
| Other Non Cash Items | -2,207,301USD | 8,650USD | 662USD |
| Change In Working Capital | 2,366,481USD | -1,856USD | 229,741USD |
| Total Cash From Operating Activities | -2,562,901USD | -1,361,305USD | -1,377,680USD |
| Capital Expenditures | -152,986USD | -99,475USD | -44,306USD |
| Free Cash Flow | -2,715,887USD | -1,460,780USD | -1,421,986USD |
| Total Cashflows From Investing Activities | -152,986USD | -99,475USD | -44,306USD |
| Total Cash From Financing Activities | 6,919,432USD | 1,152,382USD | 500,000USD |
| Change In Cash | 4,203,545USD | -308,398USD | -921,986USD |
| Begin Period Cash Flow | 872,599USD | 1,180,997USD | 2,102,983USD |
| End Period Cash Flow | 5,076,144USD | 872,599USD | 1,180,997USD |
| Other Cashflows From Investing Activities | -152,986USD | — | — |
| Investments | — | -99,475USD | -44,306USD |
| Issuance Of Capital Stock | — | 1,152,382USD | 500,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.